Thomas Fox

University College London Hospitals NHS Foundation Trust

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (11)

Fabio Candotti

Full Professor of Medicine

Lausanne University Hospital

SWITZERLAND

View details

David Sansom

University College London

UNITED KINGDOM

View details

Adriana Albuquerque

University College London

UNITED KINGDOM

View details

Despina Moshous

Imagine Institute for Genetic Diseases

FRANCE

View details

Morgane Cheminant

Associate-Professor

AP-HP

FRANCE

View details

Claire Booth

Senior Clinical Lecturer

University College London Institute of Child Health

UNITED KINGDOM

View details

Rajeev Gupta

University College London

UNITED KINGDOM

View details

Neil Halliday

NIHR Clinical Lecturer in Hepatology

University College London

UNITED KINGDOM

View details

Alan Kennedy

University College London

UNITED KINGDOM

View details

Robert Heyderman

Professor of Infectious Diseases & International Health

University College London

UNITED KINGDOM

View details

Axel Schambach

Professor

Hannover Medical School

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Fox

Research Interests

Explore related searches

Contact this professor

Articles (11)

Improving access to gene therapy for rare diseases

Access to gene therapy for rare diseases when commercialization is not fit for purpose.

Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity

Humoral and cellular responses to SARS‐CoV‐2 in patients with B‐cell haematological malignancies improve with successive vaccination

Therapeutic gene editing of T cells to correct CTLA-4 insufficiency.

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.

Gilteritinib monotherapy as a transplant bridging option for high risk FLT3-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapy

Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID‐19 with B‐cell malignancies

Gene therapy for primary immunodeficiencies

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

Response to ‘Impact of immunosuppression on mortality in critically ill COVID‐19 patients’

Collaborators (11)

Fabio Candotti

David Sansom

Adriana Albuquerque

Despina Moshous

Morgane Cheminant

Claire Booth

Rajeev Gupta

Neil Halliday

Alan Kennedy

Robert Heyderman

Axel Schambach

Make your next move.